GW Pharma cannabis drug set to hit market following DEA nod

U.S.: listed shares of GW Pharmaceuticals rose 8 percent on Thursday as its marijuana-based treatment Epidiolex cleared the last hurdle after the Drug Enforcement Administration labeled the drug as having a low abuse potential.

The company said it would bring the drug to the market within the next six weeks.

The DEA gave Epidiolex a “Schedule V” classification, the lowest of the five schedules into which controlled substances are categorized, marking the drug as a chemical with medicinal properties and a low potential for abuse.

Marijuana, from which Epidiolex is derived, is classified as a Schedule I substance.

“We know there is excitement for a standardized version of cannabidiol that has undergone the rigor of controlled clinical trials and been approved by the FDA,” Chief Executive Officer Justin Gover said.

In June, the U.S. Food And Drug Administration approved Epidiolex to treat rare forms of childhood epilepsy, potentially driving more research into cannabis-derived medicines.

Epidiolex is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 percent of tetrahydrocannabinol (THC), the psychoactive component that makes people high.

The firm grows its own supply of cannabis in specialized glass houses in the United Kingdom to ensure uniformity in the genetic composition of the plants, which are then processed into a liquid solution of CBD.

  • Related Posts

    • Pharma
    • July 14, 2025
    • 118 views
    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    Following an announcement by the Indian Council of Medical Research (ICMR) and Panacea Biotec Limited to initiate third phase trials, about 8,000 of the targeted 10,000 participants have enrolled in…

    • Pharma
    • July 14, 2025
    • 114 views
    In Gurgaon, illegal hospital busted, quack arrested in raid

    Gurgaon: A team from the chief minister’s flying squad conducted a raid at a private hospital in Fazalwas village on Tuesday. According to police, Shivansh Hospital, located on the Tauru…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    Enrolment in third phase clinical trials for India’s first dengue vaccine nearly complete, says ICMR

    In Gurgaon, illegal hospital busted, quack arrested in raid

    In Gurgaon, illegal hospital busted, quack arrested in raid

    Customs delivers 25 containers of seized drugs to NAFDAC

    Customs delivers 25 containers of seized drugs to NAFDAC

    License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir

    License Of Four Pharma Firms Cancelled For Illegal Drug Trade In Jammu & Kashmir